Share
Bridging the Gap Between LNP Innovation and Clinical Success
We’re proud to share that the LNP Alliance’s latest thought leadership article, “Bridging the Gap: The LNP Alliance on Translating Nucleic Acid Therapeutics from Lab to Clinic,” has been published in the June issue of Contract Pharma.
This roundtable brings together perspectives from across the LNP development ecosystem, featuring contributions from experts at NOF Corporation, Phosphorex, NeoSome Life Sciences, NanoImaging Services (NIS), and Envol Biomedical. Together, the discussion explores where LNP programs most often stall, the challenges of clinical translation, and how shared expertise across chemistry, formulation, characterization, and preclinical biology can help advance next-generation therapeutics.
Thank you to our panel of experts:
• Jerry Williamson, CEO, Phosphorex
• Jake McDonald, PhD, CEO, Envol Biomedical
• Syed Reza, MD, PhD, Licensing and External Innovation Alliance Management, NOF America Corporation
• Nicholas Boylan, PhD, Senior Director, Scientific Services, Phosphorex
• Mandy Janssen, PhD, Scientific Director, Characterization, Nano Imaging Services (NIS)
• Sara Little, Associate Director of Oncology, NeoSome Life Sciences